Joseph Kaloko

Title: Joseph Kaloko: Innovator in Glucagon Receptor Antagonists

Introduction

Joseph Kaloko is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of glucagon receptor antagonists. His work is crucial for addressing various metabolic disorders, including diabetes.

Latest Patents

Kaloko holds a patent for glucagon receptor antagonists. This patent includes solid state forms of compounds, including enantiomerically pure forms and pharmaceutically acceptable salts or co-crystals and prodrugs. These compounds exhibit glucagon receptor antagonist or inverse agonist activity. The patent also outlines pharmaceutical compositions and methods for treating, preventing, ameliorating, delaying the onset, or reducing the risk of conditions such as Type I and II diabetes, insulin resistance, hyperglycemia, ketoacidosis, or ketosis. He has 1 patent to his name.

Career Highlights

Joseph Kaloko is currently associated with Ligand Pharmaceuticals, Inc. His work at the company focuses on innovative solutions for metabolic diseases. His research has the potential to improve the quality of life for many individuals suffering from these conditions.

Collaborations

Kaloko collaborates with talented professionals in his field, including Lin Zhi and Ian Henderson. These partnerships enhance the research and development efforts at Ligand Pharmaceuticals.

Conclusion

Joseph Kaloko is a prominent figure in the pharmaceutical industry, particularly known for his work on glucagon receptor antagonists. His contributions are vital for advancing treatments for metabolic disorders.